Media Coverage

Media Coverage

Read how Vistagen’s intention to revolutionize mental health medicine is causing a buzz in the media.

image thumbnail
BioSpace Movers & Shakers, May 7
Read
image thumbnail (1)
Karyopharm taps long­time Pfiz­er, Am­gen vet to steer the ship; With Mer­ck in the rearview mir­ror, Roger Perl­mut­ter stakes his claim to a CEO job — and it's a sur­pris­ing choice
Read
image thumbnail
Chutes & Ladders—Former Merck R&D chief Perlmutter takes reins at Eikon, applying Nobel-winning tech to drug discovery
Read
BioWorld logo image.png
To read the full story, subscribe or sign in. Appointments and advancements for May 4, 2021
Read
psychiatric Times logo image.png
A Potential Benzodiazepine Replacement
Read
Thepharmaletter logo image.png
New data shows strength in VistaGen’s PH94B for SAD
Read
Medium logo image.png
Shawn Singh of VistaGen Therapeutics: 5 Ways That Businesses Can Help Promote The Mental Wellness Of Their Employees
Read
BioTuesdays logo image.png
VistaGen readies Phase 3 trial of novel, fast-acting neuroactive nasal spray in social anxiety disorder
Read
Crain's logo image.jpg
Local Biotech Firms Poised to Benefit from Rosy Venture Capital Outlook for 2021
Read